GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Excellerant EXCL · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Excellerant — daily EXCL Delayed
Market value
$1,130
Last close × shares
Volume
3
Shares, 30 Oct 2026

About Excellerant

Its shares trade under the ticker EXCL. It has been listed since 4 August 2020.

Excellerant, Inc. is a developing stage company, which engages in providing the travel medical consulting and tour guidance services. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2020-08-04. The Company’s services include consulting services in the field of traditional and alternative medicine and medical technologies in China, helping customers to choose a clinic for treatment, consulting customers and helping them to arrange the itinerary, by building a route, which includes clinics, hospitals and other medical institution and providing guide services to their potential clients. The firm also provides their customers with information concerning transportation, the cost of it, how it operates and what are the best medical institutions, as well as accommodation information. The firm primarily provides services both to legal entities and individuals.

Figures and description from our data supplier, not checked against the company's own report.

More about Excellerant →

Latest on Excellerant

Our reporting

We have not reported on Excellerant yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Excellerant's ticker?

Excellerant trades as EXCL on its US listing, under ISIN US30069M1062.

What was Excellerant's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.